麻豆传媒

Medtronic announced that the FDA approved the for the treatment of tachycardia and prevention of sudden cardiac arrest.

The , which gave clinics and hospitals financial incentives to assess and reduce cardiovascular disease, reduced heart attacks and strokes in a cluster-randomized trial. (JAMA)

Echocardiographic measurements of the were helpful for early differentiation between type A acute aortic dissection and ST-elevation myocardial infarction. (Journal of the American Heart Association)

An of the TWILIGHT and TICO trials supported the concept of monotherapy with a P2Y12 inhibitor after a short period of dual antiplatelet therapy in acute coronary syndrome. (Circulation)

Low-risk patients had a 5 years after surgical aortic valve replacement in a national cohort study. (Annals of Thoracic Surgery)

Anemic patients with severe aortic stenosis often had , which was reduced after transcatheter aortic valve replacement, a prospective study showed. (New England Journal of Medicine)

Study suggests little value of systemic family genetic screening for with hypertrophic cardiomyopathy. (Journal of the American College of Cardiology)

The SGLT2 inhibitor did not show that its ability to reduce heart failure hospitalizations applied to people with baseline ejection fractions above 60%. (European Heart Journal)

carried a relative survival advantage compared with anticoagulation alone or systemic thrombolysis in a meta-analysis. (JACC: Cardiovascular Interventions)

ECGs in sinus rhythm were mined by a deep learning model for . (JAMA Cardiology)

The benefit of remote ischemic conditioning for stroke patients seemed to hinge on whether they had . (Stroke)

Children with familial hypercholesterolemia continued to show no cognitive harms from evolocumab (Repatha) treatment in the of HAUSER-RCT. (European Journal of Preventive Cardiology)

Later-life cognition in women was tied to . (Alzheimer's & Dementia)

Comment